PLAYSTUDIOS, Inc (MYPS) Files a Proposed Offering of up to 119M Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Pre-Open Stock Movers 07/16: (GLG) (AEHR) (MGI) Higher; (FGEN) (AOUT) (CRVS) Lower (more...)
July 16, 2021 9:30 AM EDTPre-Open Stock Movers
FibroGen, Inc. (NASDAQ: FGEN) 36.2% LOWER; announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted to recommend not approving roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, for the treatment of anemia due to chronic kidney disease (CKD) in adult patients. The Committee based its recommendation on data from a global Phase 3 program encompassing more than 8,000 patients. While the FDA is not... More
After-Hours Stock Movers 07/15: (AEHR) (APT) (MRNA) Higher; (AOUT) (CRVS) Lower (more...)
July 15, 2021 6:22 PM EDTAfter-Hours Movers
Aehr Test Systems (NASDAQ: AEHR) 19.6% HIGHER; Net sales were $7.6 million, up 102% from $3.8 million in the fourth quarter of fiscal 2020.
American Outdoor Brands (NASDAQ: AOUT) 11.2% LOWER; reported Q4 EPS of $0.09, $0.14 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $64.5 million versus the consensus estimate of $62.03 million. American Outdoor Brands sees FY2022 EPS of $1.00-$1.24. American... More
UPDATE: Oppenheimer Starts PlayStudios (MYPS) at Outperform, $11 PT
July 15, 2021 4:06 PM EDT(Updated - July 15, 2021 4:56 PM EDT)
Oppenheimer analyst Martin Yang initiates coverage on PlayStudios (NASDAQ: MYPS) with a Outperform rating and a price target of $11.00.
The analyst commented, "We initiate coverage on PLAYSTUDIOS with an Outperform rating and $11 PT. MYPS'... More
